Literature DB >> 15056530

Seizures and prolonged QTc with atomoxetine overdose.

Sharad Sawant, Steven R Daviss.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15056530     DOI: 10.1176/appi.ajp.161.4.757

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  13 in total

Review 1.  The QT interval and psychotropic medications in children: recommendations for clinicians.

Authors:  Paul McNally; Fiona McNicholas; Paul Oslizlok
Journal:  Eur Child Adolesc Psychiatry       Date:  2006-08-29       Impact factor: 4.785

2.  Effects of atomoxetine on the QT interval in healthy CYP2D6 poor metabolizers.

Authors:  Corina Loghin; Harry Haber; Charles M Beasley; Prajakti A Kothare; Lynnette Kauffman; John April; Ling Jin; Albert J Allen; Malcolm I Mitchell
Journal:  Br J Clin Pharmacol       Date:  2013-02       Impact factor: 4.335

Review 3.  Cardiovascular effects of methylphenidate, amphetamines and atomoxetine in the treatment of attention-deficit hyperactivity disorder.

Authors:  Gary Stiefel; Frank M C Besag
Journal:  Drug Saf       Date:  2010-10-01       Impact factor: 5.606

4.  Long-QT Syndrome and Therapy for Attention Deficit/Hyperactivity Disorder.

Authors:  Claire Zhang; Valentina Kutyifa; Arthur J Moss; Scott McNitt; Wojciech Zareba; Elizabeth S Kaufman
Journal:  J Cardiovasc Electrophysiol       Date:  2015-08-06

5.  Inhibition of G-protein-activated inwardly rectifying K+ channels by the selective norepinephrine reuptake inhibitors atomoxetine and reboxetine.

Authors:  Toru Kobayashi; Kazuo Washiyama; Kazutaka Ikeda
Journal:  Neuropsychopharmacology       Date:  2010-03-10       Impact factor: 7.853

Review 6.  Risk of serious cardiovascular problems with medications for attention-deficit hyperactivity disorder.

Authors:  Jose Martinez-Raga; Carlos Knecht; Nestor Szerman; María I Martinez
Journal:  CNS Drugs       Date:  2013-01       Impact factor: 5.749

Review 7.  Pharmacologic management of attention deficit hyperactivity disorder in children and adolescents: a review for practitioners.

Authors:  Kelly A Brown; Sharmeen Samuel; Dilip R Patel
Journal:  Transl Pediatr       Date:  2018-01

Review 8.  Attention-deficit/hyperactivity disorder genomics: update for clinicians.

Authors:  Josephine Elia; Jillan Sackett; Terri Turner; Martin Schardt; Shih-Ching Tang; Nicole Kurtz; Maura Dunfey; Nadia A McFarlane; Aita Susi; David Danish; Alice Li; Jenelle Nissley-Tsiopinis; Karin Borgmann-Winter
Journal:  Curr Psychiatry Rep       Date:  2012-10       Impact factor: 5.285

9.  Life-threatening QT prolongation in a boy with attention-deficit/hyperactivity disorder on atomoxetine.

Authors:  Hiroshi Yamaguchi; Kiyoshi Nagumo; Taiji Nakashima; Yoshikazu Kinugawa; Satoru Kumaki
Journal:  Eur J Pediatr       Date:  2014-12       Impact factor: 3.183

10.  Atomoxetine: a novel treatment for child and adult ADHD.

Authors:  Marcialee Ledbetter
Journal:  Neuropsychiatr Dis Treat       Date:  2006-12       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.